Monday, November 6, 2017
- 9:00AM-11:00AM
-
Abstract Number: 1117
the Absolute Risk of Clinically Diagnosed Gout By Serum Uric Acid Levels – Results from 30 Years Follow-up of the Malmö Preventive Project Cohort in Southern Sweden
Metabolic and Crystal Arthropathies Poster I- 9:00AM-11:00AM
-
Abstract Number: 1023
The Autoimmune Discovery Ichip Distinguishes Healthy Individuals (HC) from Those with SLE, Rheumatoid Arthritis (RA), Scleroderma (SSc), Sjogren’s Syndrome (SS), and the Anti-Phospholipid Syndrome (APS)
Genetics, Genomics and Proteomics Poster II- 9:00AM-11:00AM
-
Abstract Number: 1408
The Cation Channel TRPV2 Decreases Rheumatoid Arthritis Fibroblast-like Synoviocyte Invasiveness By Inhibiting RhoA Activation, Cell Adhesion and Actin Cytoskeleton Changes
Rheumatoid Arthritis – Human Etiology and Pathogenesis Poster II- 9:00AM-11:00AM
-
Abstract Number: 1732
The Characteristic T-Cell Receptor-Mediated Signaling of Peripheral Blood T Cells in Dermatomyositis and Polymyositis
T Cell Biology and Targets in Autoimmune Disease Poster I- 9:00AM-11:00AM
-
Abstract Number: 981
The Common Risk Factors for Hyperuricemia and Gout Do Not Predict Incident Gout Once Hyperuricemia Is Established
Epidemiology and Public Health Poster II: Rheumatic Diseases Other than Rheumatoid Arthritis- 9:00AM-11:00AM
-
Abstract Number: 1238
The Development of the Lupus Foundation of America—Rapid Evaluation of Activity in Lupus (LFA-REAL™) Patient-Reported Outcome (PRO) to Evaluate Lupus Disease Activity
Patient Outcomes, Preferences, and Attitudes Poster II- 9:00AM-11:00AM
-
Abstract Number: 1131
The Dietary Approaches to Stop Hypertension (DASH) and Mediterranean Diets and Risk of Gout in Women: 28-Year Follow-up of a Prospective Cohort
Metabolic and Crystal Arthropathies Poster I- 9:00AM-11:00AM
-
Abstract Number: 992
The Effect of Anti-TNF Therapy on Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis over One Year – Real Life Data from the Czech Biologics Registry Attra
Epidemiology and Public Health Poster II: Rheumatic Diseases Other than Rheumatoid Arthritis- 9:00AM-11:00AM
-
Abstract Number: 1544
The Effect of Extraarticular Manifestations on Tumor Necrotic Factor α Inhibitor Drug Survival in Patients with Ankylosing Spondylitis: Nationwide Data from the Korean College of Rheumatology Biologics (KOBIO) Registry
Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment Poster II- 9:00AM-11:00AM
-
Abstract Number: 1767
The Effect on Health-Related Quality of Life of Treatment for Remission Maintenance in ANCA-Associated Vasculitis Beyond 18 Months
Vasculitis Poster II: ANCA-Associated Vasculitis- 9:00AM-11:00AM
-
Abstract Number: 1440
The Effectiveness of Zoster Vaccine in RA Patients Subsequently Treated with Tofacitinib
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy Poster II: Prognostic Factors, Imaging and Miscellaneous Reports- 9:00AM-11:00AM
-
Abstract Number: 1261
The Effects of Disease Burden, Helplessness, and Pain on Depressive Symptoms in Rheumatoid Arthritis and Systemic Lupus Erythematosus
Patient Outcomes, Preferences, and Attitudes Poster II- 9:00AM-11:00AM
-
Abstract Number: 1466
The Effects of Rituximab and B-Cells Depletion on the Inflammatory and Pro-Thrombotic Profile of Leucocytes of Rheumatoid Arthritis Patients and on the Vascular Endothelium
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy Poster II: Prognostic Factors, Imaging and Miscellaneous Reports- 9:00AM-11:00AM
-
Abstract Number: 1749
The Epidemiology of ANCA Associated Vasculitis in the U.S.: A 20 Year Population Based Study
Vasculitis Poster II: ANCA-Associated Vasculitis- 9:00AM-11:00AM
-
Abstract Number: 995
The Epidemiology of Psoriatic Arthritis in Israel – a Population-Based Study